1268713-64-9

Basic information

• Product Name: 1-BroMo-3-cyclobutoxy-benzene
• Synonyms: 1-BroMo-3-cyclobutoxy-benzene;1-bromo-3-(cyclobutyloxy)benzene
• CAS NO: 1268713-64-9
• Molecular Formula: C₁₀H₁₁BrO
• Molecular Weight: 227.09774
• EINECS: -0
• Mol File: 1268713-64-9.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-BroMo-3-cyclobutoxy-benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-BroMo-3-cyclobutoxy-benzene(1268713-64-9)
• EPA Substance Registry System: 1-BroMo-3-cyclobutoxy-benzene(1268713-64-9)

Safety Data

• Hazardous Substances Data: 1268713-64-9(Hazardous Substances Data)

Usage

Structure

Aromatic benzene ring with a bromine atom attached at the 1 position and a cyclobutoxy group at the 3 position

Appearance

Colorless liquid at room temperature

Flammability

Highly flammable

Uses

Commonly used in organic synthesis, particularly in the production of pharmaceuticals and agrochemicals

Reactivity

Known for its reactivity in various chemical reactions, making it a versatile building block for the synthesis of complex organic compounds

Handling precautions

Handle with caution due to flammability and potential health hazards

Upstream product

• 591-20-8 3-Bromophenol 
• 4399-47-7 Bromocyclobutane 

Relevant articles and documents

MTA-Cooperative PRMT5 Inhibitors

The present invention relates to compounds that inhibit Protein Arginine N-Methyl Transferase 5 (PRMT5) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

Furo[3,2-b]pyridine: A Privileged Scaffold for Highly Selective Kinase Inhibitors and Effective Modulators of the Hedgehog Pathway

Reported is the identification of the furo[3,2-b]pyridine core as a novel scaffold for potent and highly selective inhibitors of cdc-like kinases (CLKs) and efficient modulators of the Hedgehog signaling pathway. Initially, a diverse target compound set was prepared by synthetic sequences based on chemoselective metal-mediated couplings, including assembly of the furo[3,2-b]pyridine scaffold by copper-mediated oxidative cyclization. Optimization of the subseries containing 3,5-disubstituted furo[3,2-b]pyridines afforded potent, cell-active, and highly selective inhibitors of CLKs. Profiling of the kinase-inactive subset of 3,5,7-trisubstituted furo[3,2-b]pyridines revealed sub-micromolar modulators of the Hedgehog pathway.

BIARYL DERIVATIVE AS GPR120 AGONIST

The present invention relates to a biaryl derivative expressed by the chemical formula 1, a method for producing the biaryl derivative, a pharmaceutical composition comprising same, and use of same, the biaryl derivative expressed by the chemical formula 1, as a GPR120 agonist, promoting GLP-1 generation in the gastro-intestinal tract, reducing insulin resistance in the liver, muscles and the like from anti-inflammatory activity in the macrophage, pancreatic cells and the like, and allowing effective use in prevention or treatment of inflammation or metabolic diseases such as diabetes, complications from diabetes, obesity, non-alcoholic fatty liver disease, fatty liver disease, and osteoporosis.

PIPERIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

The invention relates to new piperidine derivatives of the formula (I) to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.

New piperidine derivatives, pharmaceutical compositions and uses thereof

The invention relates to new piperidine derivatives of the formula I to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.

NEW PIPERIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

The invention relates to new piperidine derivatives of the formula (I) to their use as medicaments, to methods for their therapeutic use as inhibitors of acetyl-CoA carboxylases and to pharmaceutical compositions containing them.

Piperidine Derivatives

Piperidine derivatives of which the following is exemplary and their use in the treatment of obesity, diabetes or dyslipidemia.

NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

The invention relates to new piperidine derivatives of the formula I to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.